Fetal arrhythmias: Diagnosis and current recommendations for therapy

Progress in Pediatric Cardiology

Volumn 5, Issue 2, 1996, Pages 141-147

  Crosson, Jane E ^a   Scheel, Janet N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DIGOXIN; FLECAINIDE; PROCAINAMIDE; SOTALOL; VERAPAMIL;

ECHOCARDIOGRAPHY; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; HEART ARRHYTHMIA; HUMAN; PRIORITY JOURNAL; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

EID: 0029876148     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/1058-9813(95)00159-X     Document Type: Article

References (18)

1. Kleinman CS, Cope JA, Weinstein EM, Santulli TV, Hobbins JC. In utero diagnosis and treatment of fetal supraventricular tachycardia. Semin Perinatol 1985;2:113-129.
2. Calvin SE, Gaziano EP, Bendel RP, Knox GE, Brandt DG. Evaluation of fetal cardiac arrhythmias: Ultrasound findings and neonatal outcome. Minn Med 1992;75:29-31.
3. Hansmann M, Gembruch U, Bald R, Manz M, Redel DA. Fetal tachyarrhythmias: transplacental and direct treatment of the fetus: a report of 60 cases. Ultrasound Obstet Gynecol 1991;1:162-170.
4. Ko JK, Deal BJ, Strasburger JF, Benson DW. Supraventricular tachycardia mechanisms and their aged distribution in pediatric patients. Am J Cardiol 1992;69:1028-1032.
5. Crosson JE, Hesslein PS, Thilenius OG, Dunnigan A. AV node reentry tachycardia in infants. PACE 1995;18:2144-2149.
6. Van Engelen AD, Weitjens O, Brenner JI et al. Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994;24:1371-1375.
7. Johnson WH, Dunnigan A, Fehr P, Benson DW. Association of atrial flutter and orthodromic reciprocating fetal tachycardia. Am J Cardiol 1987; 59:374-375.
8. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J 1991; 65:46-48.
9. Hallak M, Neerhof MG, Perry R, Nazir M, Huhta JC. Fetal supraventricular tachycardia and hydrops fetalis: combined intensive, direct and transplacental therapy. Obstet Gynecol 1991; 78:523-525.
10. Weiner CP, Thompson MIB: Direct treatment of fetal supraventricular tachycardia after failed transplacental therapy. Am J Obstet Gynecol 1988; 158:570-573.
11. Dubin AM, Kleinman CS, Copel JA, Rosenfeld LE. Update on fetal tachycardia: report of a series of 21 patients. Circulation 1994; 90:I-99.
12. Naheed ZJ, Deal BJ, Gidding SS, Benson DW, Strasburger JF. Natural history of fetal supraventricular tachycardia in patients with and without hydrops fetalis. Circulation 1994; 90:I-99.
13. Dumesic DA, Silverman NH, Tobias S, Golbus MS. Transplacental cardioversion of fetal supraventricular tachycardia with procainamide. N Engl J Med 1982; 307:1128-1131.
14. Kleinman CS, Copel JA. Electrophysiological principles and fetal antiarrhythmic therapy. Ultrasound Obstet Gynecol 1991; 1:286-297.
15. Spinnato JA, Shaver DC, Flinn GS, Sibai BM, Watson DL, Marin-Garcia J. Fetal supraventricular tachycardia: In utero therapy with digoxin and quinidine. Obstet Gynecol 1984; 64:730-735.
16. Fish FH, Gillette PC, Benson DW. Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. J Am Coll Cardiol 1991; 18:356-365.
17. Tipple M, Snador G. Efficacy and safety of oral sotalol in early infancy. PACE 1991; 14:2062-2065.
18. Stevens DC, Schriener RL, Hurwitz PA, Gresham EL. Fetal and neonatal ventricular arrhythmia. Pediatrics 1979; 63:771-777.